Clinical Trial: Cell Therapy in Limb Girdle Muscular Dystrophy

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: Intrathecal Autologous Mononuclear Cell Therapy for Limb Girdle Muscular Dystrophy

Brief Summary: The purpose of this study was to study the effect of stem cell therapy on Limb Girdle Muscular Dystrophy patients.

Detailed Summary:
Sponsor: Neurogen Brain and Spine Institute

Current Primary Outcome: Change in Functional Independence Measure (FIM) scale [ Time Frame: 1 year ]

Functional Independence Measure scale assesses the patients ability to carry out activities of daily living. At the follow up of 1 year, every patient in this study will be reevaluated on this scale.


Original Primary Outcome: Same as current

Current Secondary Outcome: Change in Manual Muscle Testing (MMT) [ Time Frame: 1 year ]

Manual muscle testing is a procedure for the evaluation of the function and strength of individual muscles and muscle groups based on the effective performance of a movement in relation to the forces of gravity and manual resistance. On the follow up after 1 year, every patient will be reassessed on MMT to record changes in their muscle strength after stem cell therapy.


Original Secondary Outcome: Same as current

Information By: Neurogen Brain and Spine Institute

Dates:
Date Received: September 12, 2014
Date Started: December 2010
Date Completion:
Last Updated: September 23, 2016
Last Verified: September 2016